Type I Thyroplasty or Fat Injection Laryngoplasty Versus Arytenoid Adduction: Effects of Surgery on Voice Recovery in Patients With Unilateral Vocal Fold Paralysis
Ear, Nose & Throat Journal · 2025
DOI: 10.1177/01455613231176153 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Ear, Nose & Throat Journal, 2025. Verfasst von Akihito Hasukawa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology and Head and Neck Surgery, Nara Medical University, Nara, Japan. Hauptthemen laut MEDLINE: Vocal Cord Paralysis, Laryngoplasty, Arytenoid Cartilage, Adipose Tissue. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Objective
Type I (medialization) thyroplasty (MT), fat injection laryngoplasty (FIL), and arytenoid adduction (AA) are the 3 most common surgical treatments for unilateral vocal fold paralysis (UVFP). While MT and FIL involve medialization of the paralyzed vocal fold, the goal of AA is to reduce the glottal-level difference. The current study compared the effects of these surgical treatments on voice quality in patients with UVFP.
Methods
This retrospective study included 87 patients with UVFP who underwent MT (n = 12), FIL (n = 31), AA (n = 6), or AA with MT (n = 38). Patients who underwent the former 2 surgical treatments were included in the thyroplasty (TP) group, while those who underwent the latter 2 were included in the AA group. Maximum phonation time (MPT), pitch period perturbation quotient (PPQ), amplitude perturbation quotient, and harmonic-to-noise ratio (HNR) were evaluated in all patients before and 1 month after surgery.
Results
The TP group exhibited significant improvements in MPT ( P < .001) and PPQ ( P = .012), while the AA group exhibited significant improvements in all parameters ( P < .001). Before surgery, voice quality was significantly worse in the AA group than in the TP group for all measures. However, there were no significant differences between the groups after treatment.
Conclusion
Surgeries in both groups were effective for voice recovery in patients with UVFP under the appropriate surgical selection. Our results also highlight the importance of preoperative evaluation and the potential value of etiology for selecting the appropriate procedure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology and Head and Neck Surgery, Nara Medical University, Nara, Japan.
- Department of Otolaryngology and Osaka Voice Center, Osaka Kaisei Hospital, Osaka, Japan.
- Sakamoto ENT Clinic, Osaka, Japan.
ORCID-Profile: Akihito Hasukawa, Tadashi Kitahara
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Ministry of Health, Labour and Welfare
Zitieren
APA
Hasukawa, A., Mochizuki, R., Sakamoto, H., Shibano, A., & Kitahara, T. (2025). Type I Thyroplasty or Fat Injection Laryngoplasty Versus Arytenoid Adduction: Effects of Surgery on Voice Recovery in Patients With Unilateral Vocal Fold Paralysis. Ear, Nose & Throat Journal. https://doi.org/10.1177/01455613231176153
Vancouver
Hasukawa A, Mochizuki R, Sakamoto H, Shibano A, Kitahara T. Type I Thyroplasty or Fat Injection Laryngoplasty Versus Arytenoid Adduction: Effects of Surgery on Voice Recovery in Patients With Unilateral Vocal Fold Paralysis. Ear, Nose & Throat Journal. 2025. doi:10.1177/01455613231176153
BibTeX
@article{Hasukawa2025,
author = {Hasukawa, Akihito and Mochizuki, Ryuichi and Sakamoto, Hiramori and Shibano, Akira and Kitahara, Tadashi},
title = {Type I Thyroplasty or Fat Injection Laryngoplasty Versus Arytenoid Adduction: Effects of Surgery on Voice Recovery in Patients With Unilateral Vocal Fold Paralysis},
journal = {Ear, Nose & Throat Journal},
year = {2025},
doi = {10.1177/01455613231176153}
}
EUVIMED